bpc-157 safety human case reports adverse effects Should the FDA ease restrictions on compounded peptides? The debate is heating up. ⚠️ An FDA advisory panel is voting this week on whether to allow seven peptides—including TB-500 and BPC-157—to be FDA panel backs unapproved peptides

Baseline labs anchor the decision: bloodwork is ordered before any vial is opened, not after the patient is already cycling

MOTS-c Strength: 50 mg Mitochondrial-derived peptide Expanded-strength option for patients seeking more advanced metabolic and recovery support strategies

Low NAD+ levels may cause aging, cancer, metabolic disease, sarcopenia, and frailty

Mitochondrial NAD(+) deficiency in vascular smooth muscle impairs collagen III [PMID: 39843801] Laboratory literature summary: Mitochondrial NAD(+) deficiency in vascular smooth muscle impairs collagen III turnover to trigger thoracic and abdominal aortic aneurysm